Changes

m
no edit summary
Line 2,988: Line 2,988:     
==WHO Central Nervous System Tumours  (5th ed.) Content==
 
==WHO Central Nervous System Tumours  (5th ed.) Content==
 +
 +
}
 
{| class="wikitable"
 
{| class="wikitable"
 
|-
 
|-
Line 2,998: Line 3,000:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
|   Astrocytoma, IDH-mutant||Disease||
+
|Astrocytoma, IDH-mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,006: Line 3,008:  
|
 
|
 
|-
 
|-
|   Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
+
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
 
|
 
|
 
|
 
|
Line 3,014: Line 3,016:  
|
 
|
 
|-
 
|-
|   Glioblastoma, IDH-wildtype||Disease||
+
|Glioblastoma, IDH-wildtype||Disease||
 
|
 
|
 
|
 
|
Line 3,022: Line 3,024:  
|
 
|
 
|-
 
|-
|   Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
+
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
 
|
 
|
 
|
 
|
Line 3,030: Line 3,032:  
|
 
|
 
|-
 
|-
|   Angiocentric glioma||Disease||
+
|Angiocentric glioma||Disease||
 
|
 
|
 
|
 
|
Line 3,038: Line 3,040:  
|
 
|
 
|-
 
|-
|   Polymorphous low-grade neuroepithelial tumour of the young||Disease||
+
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
 
|
 
|
 
|
 
|
Line 3,046: Line 3,048:  
|
 
|
 
|-
 
|-
|   Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
+
|Diffuse low-grade glioma, MAPK pathway-altered||Disease||
 
|
 
|
 
|
 
|
Line 3,054: Line 3,056:  
|
 
|
 
|-
 
|-
|   Diffuse midline glioma, H3 K27-altered||Disease||
+
|Diffuse midline glioma, H3 K27-altered||Disease||
 
|
 
|
 
|
 
|
Line 3,062: Line 3,064:  
|
 
|
 
|-
 
|-
|   Diffuse hemispheric glioma, H3 G34-mutant||Disease||
+
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,070: Line 3,072:  
|
 
|
 
|-
 
|-
|   Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
+
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
 
|
 
|
 
|
 
|
Line 3,078: Line 3,080:  
|
 
|
 
|-
 
|-
|   Infant-type hemispheric glioma||Disease||
+
|Infant-type hemispheric glioma||Disease||
 
|
 
|
 
|
 
|
Line 3,086: Line 3,088:  
|
 
|
 
|-
 
|-
|   Pilocytic astrocytoma ||Disease||
+
|Pilocytic astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,094: Line 3,096:  
|
 
|
 
|-
 
|-
|   High-grade astrocytoma with piloid features||Disease||
+
|High-grade astrocytoma with piloid features||Disease||
 
|
 
|
 
|
 
|
Line 3,102: Line 3,104:  
|
 
|
 
|-
 
|-
|   Pleomorphic xanthoastrocytoma||Disease||
+
|Pleomorphic xanthoastrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,110: Line 3,112:  
|
 
|
 
|-
 
|-
|   Subependymal giant cell astrocytoma||Disease||
+
|Subependymal giant cell astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,118: Line 3,120:  
|
 
|
 
|-
 
|-
|   Chordoid glioma||Disease||
+
|Chordoid glioma||Disease||
 
|
 
|
 
|
 
|
Line 3,126: Line 3,128:  
|
 
|
 
|-
 
|-
|   Astroblastoma, MN1-altered||Disease||
+
|Astroblastoma, MN1-altered||Disease||
 
|
 
|
 
|
 
|
Line 3,134: Line 3,136:  
|
 
|
 
|-
 
|-
|   Ganglioglioma||Disease||
+
|Ganglioglioma||Disease||
 
|
 
|
 
|
 
|
Line 3,142: Line 3,144:  
|
 
|
 
|-
 
|-
|   Gangliocytoma||Disease||
+
|Gangliocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,150: Line 3,152:  
|
 
|
 
|-
 
|-
|   Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
+
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,158: Line 3,160:  
|
 
|
 
|-
 
|-
|   Dysembryoplastic neuroepithelial tumour||Disease||
+
|Dysembryoplastic neuroepithelial tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,166: Line 3,168:  
|
 
|
 
|-
 
|-
|   Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
+
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
 
|
 
|
 
|
 
|
Line 3,174: Line 3,176:  
|
 
|
 
|-
 
|-
|   Papillary glioneuronal tumour||Disease||
+
|Papillary glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,182: Line 3,184:  
|
 
|
 
|-
 
|-
|   Rosette-forming glioneuronal tumour||Disease||
+
|Rosette-forming glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,190: Line 3,192:  
|
 
|
 
|-
 
|-
|   Myxoid glioneuronal tumour||Disease||
+
|Myxoid glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,198: Line 3,200:  
|
 
|
 
|-
 
|-
|   Diffuse leptomeningeal glioneuronal tumour||Disease||
+
|Diffuse leptomeningeal glioneuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,206: Line 3,208:  
|
 
|
 
|-
 
|-
|   Multinodular and vacuolating neuronal tumour||Disease||
+
|Multinodular and vacuolating neuronal tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,214: Line 3,216:  
|
 
|
 
|-
 
|-
|   Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
+
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
 
|
 
|
 
|
 
|
Line 3,222: Line 3,224:  
|
 
|
 
|-
 
|-
|   Central neurocytoma||Disease||
+
|Central neurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,230: Line 3,232:  
|
 
|
 
|-
 
|-
|   Extraventricular neurocytoma||Disease||
+
|Extraventricular neurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,238: Line 3,240:  
|
 
|
 
|-
 
|-
|   Cerebellar liponeurocytoma||Disease||
+
|Cerebellar liponeurocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,246: Line 3,248:  
|
 
|
 
|-
 
|-
|   Supratentorial ependymoma||Disease||
+
|Supratentorial ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,254: Line 3,256:  
|
 
|
 
|-
 
|-
|   Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
+
|Supratentorial ependymoma, ZFTA fusion-positive||Disease||
 
|
 
|
 
|
 
|
Line 3,262: Line 3,264:  
|
 
|
 
|-
 
|-
|   Supratentorial ependymoma, YAP1 fusion-positive||Disease||
+
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
 
|
 
|
 
|
 
|
Line 3,270: Line 3,272:  
|
 
|
 
|-
 
|-
|   Posterior fossa ependymoma||Disease||
+
|Posterior fossa ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,278: Line 3,280:  
|
 
|
 
|-
 
|-
|   Posterior fossa group A (PFA) ependymoma||Disease||
+
|Posterior fossa group A (PFA) ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,286: Line 3,288:  
|
 
|
 
|-
 
|-
|   Posterior fossa group B (PFB) ependymoma||Disease||
+
|Posterior fossa group B (PFB) ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,294: Line 3,296:  
|
 
|
 
|-
 
|-
|   Spinal ependymoma||Disease||
+
|Spinal ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,302: Line 3,304:  
|
 
|
 
|-
 
|-
|   Spinal ependymoma, MYCN-amplified||Disease||
+
|Spinal ependymoma, MYCN-amplified||Disease||
 
|
 
|
 
|
 
|
Line 3,310: Line 3,312:  
|
 
|
 
|-
 
|-
|   Myxopapillary ependymoma||Disease||
+
|Myxopapillary ependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,318: Line 3,320:  
|
 
|
 
|-
 
|-
|   Subependymoma||Disease||
+
|Subependymoma||Disease||
 
|
 
|
 
|
 
|
Line 3,326: Line 3,328:  
|
 
|
 
|-
 
|-
|   Choroid plexus papilloma||Disease||
+
|Choroid plexus papilloma||Disease||
 
|
 
|
 
|
 
|
Line 3,334: Line 3,336:  
|
 
|
 
|-
 
|-
|   Atypical choroid plexus papilloma||Disease||
+
|Atypical choroid plexus papilloma||Disease||
 
|
 
|
 
|
 
|
Line 3,342: Line 3,344:  
|
 
|
 
|-
 
|-
|   Choroid plexus carcinoma||Disease||
+
|Choroid plexus carcinoma||Disease||
 
|
 
|
 
|
 
|
Line 3,350: Line 3,352:  
|
 
|
 
|-
 
|-
|   Medulloblastoma, WNT-activated||Disease||
+
|Medulloblastoma, WNT-activated||Disease||
 
|
 
|
 
|
 
|
Line 3,358: Line 3,360:  
|
 
|
 
|-
 
|-
|   Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
+
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
 
|
 
|
 
|
 
|
Line 3,366: Line 3,368:  
|
 
|
 
|-
 
|-
|   Medulloblastoma, SHH-activated and TP53-mutant||Disease||
+
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,374: Line 3,376:  
|
 
|
 
|-
 
|-
|   Medulloblastoma, non-WNT/non-SHH||Disease||
+
|Medulloblastoma, non-WNT/non-SHH||Disease||
 
|
 
|
 
|
 
|
Line 3,382: Line 3,384:  
|
 
|
 
|-
 
|-
|   Medulloblastoma, histologically defined||Disease||
+
|Medulloblastoma, histologically defined||Disease||
 
|
 
|
 
|
 
|
Line 3,390: Line 3,392:  
|
 
|
 
|-
 
|-
|   Atypical teratoid/rhabdoid tumour||Disease||
+
|Atypical teratoid/rhabdoid tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,398: Line 3,400:  
|
 
|
 
|-
 
|-
|   Cribriform neuroepithelial tumour||Disease||
+
|Cribriform neuroepithelial tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,406: Line 3,408:  
|
 
|
 
|-
 
|-
|   Embryonal tumour with multilayered rosettes||Disease||
+
|Embryonal tumour with multilayered rosettes||Disease||
 
|
 
|
 
|
 
|
Line 3,414: Line 3,416:  
|
 
|
 
|-
 
|-
|   CNS neuroblastoma, FOXR2-activated||Disease||
+
|CNS neuroblastoma, FOXR2-activated||Disease||
 
|
 
|
 
|
 
|
Line 3,422: Line 3,424:  
|
 
|
 
|-
 
|-
|   CNS tumour with BCOR internal tandem duplication||Disease||
+
|CNS tumour with BCOR internal tandem duplication||Disease||
 
|
 
|
 
|
 
|
Line 3,430: Line 3,432:  
|
 
|
 
|-
 
|-
|   CNS embryonal tumour NEC/NOS||Disease||
+
|CNS embryonal tumour NEC/NOS||Disease||
 
|
 
|
 
|
 
|
Line 3,438: Line 3,440:  
|
 
|
 
|-
 
|-
|   Pineocytoma||Disease||
+
|Pineocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,446: Line 3,448:  
|
 
|
 
|-
 
|-
|   Pineal parenchymal tumour of intermediate differentiation||Disease||
+
|Pineal parenchymal tumour of intermediate differentiation||Disease||
 
|
 
|
 
|
 
|
Line 3,454: Line 3,456:  
|
 
|
 
|-
 
|-
|   Pineoblastoma||Disease||
+
|Pineoblastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,462: Line 3,464:  
|
 
|
 
|-
 
|-
|   Papillary tumour of the pineal region||Disease||
+
|Papillary tumour of the pineal region||Disease||
 
|
 
|
 
|
 
|
Line 3,470: Line 3,472:  
|
 
|
 
|-
 
|-
|   Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
+
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,478: Line 3,480:  
|
 
|
 
|-
 
|-
|   Schwannoma||Disease||
+
|Schwannoma||Disease||
 
|
 
|
 
|
 
|
Line 3,486: Line 3,488:  
|
 
|
 
|-
 
|-
|   Neurofibroma||Disease||
+
|Neurofibroma||Disease||
 
|
 
|
 
|
 
|
Line 3,494: Line 3,496:  
|
 
|
 
|-
 
|-
|   Perineurioma||Disease||
+
|Perineurioma||Disease||
 
|
 
|
 
|
 
|
Line 3,502: Line 3,504:  
|
 
|
 
|-
 
|-
|   Hybrid nerve sheath tumours||Disease||
+
|Hybrid nerve sheath tumours||Disease||
 
|
 
|
 
|
 
|
Line 3,510: Line 3,512:  
|
 
|
 
|-
 
|-
|   Malignant melanotic nerve sheath tumour||Disease||
+
|Malignant melanotic nerve sheath tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,518: Line 3,520:  
|
 
|
 
|-
 
|-
|   Malignant peripheral nerve sheath tumour||Disease||
+
|Malignant peripheral nerve sheath tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,526: Line 3,528:  
|
 
|
 
|-
 
|-
|   Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
+
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
 
|
 
|
 
|
 
|
Line 3,534: Line 3,536:  
|
 
|
 
|-
 
|-
|   Meningioma||Disease||
+
|Meningioma||Disease||
 
|
 
|
 
|
 
|
Line 3,542: Line 3,544:  
|
 
|
 
|-
 
|-
|   Solitary fibrous tumour||Disease||
+
|Solitary fibrous tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,550: Line 3,552:  
|
 
|
 
|-
 
|-
|   Haemangiomas and vascular malformations||Disease||
+
|Haemangiomas and vascular malformations||Disease||
 
|
 
|
 
|
 
|
Line 3,558: Line 3,560:  
|
 
|
 
|-
 
|-
|   Haemangioblastoma||Disease||
+
|Haemangioblastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,566: Line 3,568:  
|
 
|
 
|-
 
|-
|   Rhabdomyosarcoma||Disease||
+
|Rhabdomyosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,574: Line 3,576:  
|
 
|
 
|-
 
|-
|   Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
+
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
 
|
 
|
 
|
 
|
Line 3,582: Line 3,584:  
|
 
|
 
|-
 
|-
|   CIC-rearranged sarcoma||Disease||
+
|CIC-rearranged sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,590: Line 3,592:  
|
 
|
 
|-
 
|-
|   Primary intracranial sarcoma, DICER1-mutant||Disease||
+
|Primary intracranial sarcoma, DICER1-mutant||Disease||
 
|
 
|
 
|
 
|
Line 3,598: Line 3,600:  
|
 
|
 
|-
 
|-
|   Ewing sarcoma||Disease||
+
|Ewing sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,606: Line 3,608:  
|
 
|
 
|-
 
|-
|   Mesenchymal chondrosarcoma||Disease||
+
|Mesenchymal chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,614: Line 3,616:  
|
 
|
 
|-
 
|-
|   Chondrosarcoma||Disease||
+
|Chondrosarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,622: Line 3,624:  
|
 
|
 
|-
 
|-
|   Chordoma||Disease||
+
|Chordoma||Disease||
 
|
 
|
 
|
 
|
Line 3,630: Line 3,632:  
|
 
|
 
|-
 
|-
|   Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
+
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
 
|
 
|
 
|
 
|
Line 3,638: Line 3,640:  
|
 
|
 
|-
 
|-
|   Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
+
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
 
|
 
|
 
|
 
|
Line 3,646: Line 3,648:  
|
 
|
 
|-
 
|-
|   Primary diffuse large B-cell lymphoma of the CNS||Disease||
+
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,654: Line 3,656:  
|
 
|
 
|-
 
|-
|   Immunodeficiency-associated CNS lymphomas||Disease||
+
|Immunodeficiency-associated CNS lymphomas||Disease||
 
|
 
|
 
|
 
|
Line 3,662: Line 3,664:  
|
 
|
 
|-
 
|-
|   Lymphomatoid granulomatosis||Disease||
+
|Lymphomatoid granulomatosis||Disease||
 
|
 
|
 
|
 
|
Line 3,670: Line 3,672:  
|
 
|
 
|-
 
|-
|   Intravascular large B-cell lymphoma||Disease||
+
|Intravascular large B-cell lymphoma||Disease||
 
|
 
|
 
|
 
|
Line 3,678: Line 3,680:  
|
 
|
 
|-
 
|-
|   MALT lymphoma of the dura||Disease||
+
|MALT lymphoma of the dura||Disease||
 
|
 
|
 
|
 
|
Line 3,686: Line 3,688:  
|
 
|
 
|-
 
|-
|   Other low-grade B-cell lymphomas of the CNS||Disease||
+
|Other low-grade B-cell lymphomas of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,694: Line 3,696:  
|
 
|
 
|-
 
|-
|   Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
+
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
 
|
 
|
 
|
 
|
Line 3,702: Line 3,704:  
|
 
|
 
|-
 
|-
|   T-cell and NK/T-cell lymphomas||Disease||
+
|T-cell and NK/T-cell lymphomas||Disease||
 
|
 
|
 
|
 
|
Line 3,710: Line 3,712:  
|
 
|
 
|-
 
|-
|   Erdheim-Chester disease||Disease||
+
|Erdheim-Chester disease||Disease||
 
|
 
|
 
|
 
|
Line 3,718: Line 3,720:  
|
 
|
 
|-
 
|-
|   Rosai-Dorfman disease||Disease||
+
|Rosai-Dorfman disease||Disease||
 
|
 
|
 
|
 
|
Line 3,726: Line 3,728:  
|
 
|
 
|-
 
|-
|   Juvenile xanthogranuloma||Disease||
+
|Juvenile xanthogranuloma||Disease||
 
|
 
|
 
|
 
|
Line 3,734: Line 3,736:  
|
 
|
 
|-
 
|-
|   Langerhans cell histiocytosis||Disease||
+
|Langerhans cell histiocytosis||Disease||
 
|
 
|
 
|
 
|
Line 3,742: Line 3,744:  
|
 
|
 
|-
 
|-
|   Histiocytic sarcoma||Disease||
+
|Histiocytic sarcoma||Disease||
 
|
 
|
 
|
 
|
Line 3,750: Line 3,752:  
|
 
|
 
|-
 
|-
|   Germ cell tumours of the CNS||Disease||
+
|Germ cell tumours of the CNS||Disease||
 
|
 
|
 
|
 
|
Line 3,758: Line 3,760:  
|
 
|
 
|-
 
|-
|   Adamantinomatous craniopharyngioma||Disease||
+
|Adamantinomatous craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
Line 3,766: Line 3,768:  
|
 
|
 
|-
 
|-
|   Papillary craniopharyngioma||Disease||
+
|Papillary craniopharyngioma||Disease||
 
|
 
|
 
|
 
|
Line 3,774: Line 3,776:  
|
 
|
 
|-
 
|-
|   Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
+
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
 
|
 
|
 
|
 
|
Line 3,782: Line 3,784:  
|
 
|
 
|-
 
|-
|   Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
+
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
 
|
 
|
 
|
 
|
Line 3,790: Line 3,792:  
|
 
|
 
|-
 
|-
|   Pituitary blastoma||Disease||
+
|Pituitary blastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,798: Line 3,800:  
|
 
|
 
|-
 
|-
|   Metastases to the brain and spinal cord parenchyma||Disease||
+
|Metastases to the brain and spinal cord parenchyma||Disease||
 
|
 
|
 
|
 
|
Line 3,806: Line 3,808:  
|
 
|
 
|-
 
|-
|   Metastases to the meninges||Disease||
+
|Metastases to the meninges||Disease||
 
|
 
|
 
|
 
|
Line 3,814: Line 3,816:  
|
 
|
 
|-
 
|-
|   Neurofibromatosis type 1||Disease||
+
|Neurofibromatosis type 1||Disease||
 
|
 
|
 
|
 
|
Line 3,822: Line 3,824:  
|
 
|
 
|-
 
|-
|   Neurofibromatosis type 2||Disease||
+
|Neurofibromatosis type 2||Disease||
 
|
 
|
 
|
 
|
Line 3,830: Line 3,832:  
|
 
|
 
|-
 
|-
|   Schwannomatosis||Disease||
+
|Schwannomatosis||Disease||
 
|
 
|
 
|
 
|
Line 3,838: Line 3,840:  
|
 
|
 
|-
 
|-
|   Von Hippel-Lindau syndrome||Disease||
+
|Von Hippel-Lindau syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,846: Line 3,848:  
|
 
|
 
|-
 
|-
|   Tuberous sclerosis||Disease||
+
|Tuberous sclerosis||Disease||
 
|
 
|
 
|
 
|
Line 3,854: Line 3,856:  
|
 
|
 
|-
 
|-
|   Li-Fraumeni syndrome||Disease||
+
|Li-Fraumeni syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,862: Line 3,864:  
|
 
|
 
|-
 
|-
|   Cowden syndrome||Disease||
+
|Cowden syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,870: Line 3,872:  
|
 
|
 
|-
 
|-
|   Constitutional mismatch repair deficiency syndrome||Disease||
+
|Constitutional mismatch repair deficiency syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,878: Line 3,880:  
|
 
|
 
|-
 
|-
|   Familial adenomatous polyposis 1||Disease||
+
|Familial adenomatous polyposis 1||Disease||
 
|
 
|
 
|
 
|
Line 3,886: Line 3,888:  
|
 
|
 
|-
 
|-
|   Naevoid basal cell carcinoma syndrome||Disease||
+
|Naevoid basal cell carcinoma syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,894: Line 3,896:  
|
 
|
 
|-
 
|-
|   Rhabdoid tumour predisposition syndrome||Disease||
+
|Rhabdoid tumour predisposition syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,902: Line 3,904:  
|
 
|
 
|-
 
|-
|   Carney complex||Disease||
+
|Carney complex||Disease||
 
|
 
|
 
|
 
|
Line 3,910: Line 3,912:  
|
 
|
 
|-
 
|-
|   DICER1 syndrome||Disease||
+
|DICER1 syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,918: Line 3,920:  
|
 
|
 
|-
 
|-
|   Familial paraganglioma syndromes||Disease||
+
|Familial paraganglioma syndromes||Disease||
 
|
 
|
 
|
 
|
Line 3,926: Line 3,928:  
|
 
|
 
|-
 
|-
|   Melanoma-astrocytoma syndrome||Disease||
+
|Melanoma-astrocytoma syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,934: Line 3,936:  
|
 
|
 
|-
 
|-
|   Familial retinoblastoma||Disease||
+
|Familial retinoblastoma||Disease||
 
|
 
|
 
|
 
|
Line 3,942: Line 3,944:  
|
 
|
 
|-
 
|-
|   BAP1 tumour predisposition syndrome||Disease||
+
|BAP1 tumour predisposition syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,950: Line 3,952:  
|
 
|
 
|-
 
|-
|   Fanconi anaemia||Disease||
+
|Fanconi anaemia||Disease||
 
|
 
|
 
|
 
|
Line 3,958: Line 3,960:  
|
 
|
 
|-
 
|-
|   ELP1-medulloblastoma syndrome||Disease||
+
|ELP1-medulloblastoma syndrome||Disease||
 
|
 
|
 
|
 
|
Line 3,966: Line 3,968:  
|
 
|
 
|-
 
|-
}
+
|}